Investment Management Cases

Melbye Invest AB, which is the 100% owner of Melbye Invest Aps, owns 50%  of the A-shares in Milestones Capital Standard Program A/S (MC).

In addition to this investment, Melbye Invest also owns 1,8 mio. B-shares in MC.

Melbye Invest has invested in www.antev.co.uk, a clinical-stage biopharmaceutical company focused on the development of a robust registration-ready data package in areas of unmet clinical need for men´s health: prostate cancer, benign prostatic hyperplasia (BPH) and acute urinary retention (AUR), and establishing value in woman´s health indications: endometriosis and uterine fibroids.

Melbye Invest invested indirectly in the the Swedish IT consulting company m3cs AB (www.m3cs.se) august 2021.

m3cs was sold to CombinedX February 2024.